Absence of SNCA polymorphisms in Pakistani Parkinsons disease patients

J Pak Med Assoc. 2017 Oct;67(10):1512-1516.

Abstract

Objective: To elucidate the genetic risk and role of alpha-synuclein gene in the pathogenesis of Parkinson's disease in Pakistani population.

Methods: This case-control study was conducted at Institute of Biomedical and Genetic Engineering (IBGE), Islamabad from May 2013 to May 2016, and comprised patients with Parkinson's disease and their ethnically-matched healthy controls. Allele-specific polymerase chain reaction was used for screening of three pathogenic single nucleotide polymorphisms in alpha-synuclein gene. Moreover, 20% samples were randomly selected for bidirectional Sanger sequencing to confirm the results. SPSS 13 was used for data analysis.

Results: Of the 374 participants, 174(46.5%) were patients and 200(53.5%) were controls. The mean age for the onset of the disease was 55±13 years. No polymorphism was observed for rs104893875(G>A), rs104893877(G>A) and rs104893878(C>G) in alpha-synuclein gene in samples of patients and controls.

Conclusions: Alpha-synuclein gene mutations might not be relevant to all the populations in causing Parkinson's disease.

Keywords: Parkinson's disease, a-Synuclein gene, Pakistani population, Allele-specific PCR, SNCA..

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Humans
  • Middle Aged
  • Pakistan / epidemiology
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide / genetics*
  • alpha-Synuclein / genetics*

Substances

  • SNCA protein, human
  • alpha-Synuclein